✦ LIBER ✦

Treatment of patients with refractory, C-KIT positive, acute myeloid leukemia with SU5416, a novel receptor tyrosine kinase inhibitor

✍ Scribed by W. Fiedler; P. Staib; R. Kuse; U. Dührsen; M. Flasshove; V. Spataro; S. Kelsey; P. Scigalla; D.K. Hossfeld; W.E. Berdel

Book ID: 117657979
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 186 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)80609-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of SU5416—a small-molecul

Phase II study of SU5416—a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor—in patients with refractory myeloproliferative diseases

✍ Francis J. Giles; Maureen A. Cooper; Lewis Silverman; Judith E. Karp; Jeffrey E. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract ## BACKGROUND Increased bone marrow angiogenesis and vascular endothelial growth factor (VEGF) levels are of adverse prognostic significance in patients with myeloproliferative disorders (MPD), including agnogenic myeloid metaplasia (AMM), chronic myeloid leukemia in blastic phase (CML

Ponatinib: A New Tyrosine Kinase Inhibit

Ponatinib: A New Tyrosine Kinase Inhibitor for the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

✍ Shamroe, C. L.; Comeau, J. M. 📂 Article 📅 2013 🏛 Harvey Whitney Books Company 🌐 English ⚖ 288 KB

Treatment with FLT3 inhibitor in patient

Treatment with FLT3 inhibitor in patients with FLT3 -mutated acute myeloid leukemia is associated with development of secondary FLT3 -tyrosine kinase domain mutations

✍ Alvarado, Yesid; Kantarjian, Hagop M.; Luthra, Rajyalakshmi; Ravandi, Farhad; Bo 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Identification of AKN-032, a novel 2-ami

Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia

✍ Anna Eriksson; Martin Höglund; Elin Lindhagen; Anna Åleskog; Sadia Bashir Hassan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 517 KB

Design, Synthesis, and Evaluation of a N

Design, Synthesis, and Evaluation of a Novel Dual Fms-Like Tyrosine Kinase 3/Stem Cell Factor Receptor (FLT3/c-KIT) Inhibitor for the Treatment of Acute Myelogenous Leukemia

✍ Davies, Robert J.; Pierce, Albert C.; Forster, Cornelia; Grey, Ron; Xu, Jinwang; 📂 Article 📅 2011 🏛 American Chemical Society 🌐 English ⚖ 945 KB

Absence of mutations in the deoxycytidin

Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML)

✍ van den Heuvel-Eibrink, M M; Wiemer, E A C; Kuijpers, M; Pieters, R; Sonneveld, 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 80 KB